Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Certain medications can cause serious side effects, so it's important to report them.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Sonidegib and vismodegib have different side effects and reporting patterns.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.